Videos

Carol Ann Huff, MD, describes her institution's multidisciplinary approach to monitoring for adverse events when administering bispecific antibodies, including the roles of nurses, pharmacists, and attending physicians.

Michael Singel, PharmD; and Carol Ann Huff, MD, discuss how step-up dosing for bispecific antibodies has been implemented in the outpatient setting with monitoring considerations for cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome to ensure patient safety.

The vice president and chief pharmacy officer at City of Hope explains how she serves as a mentor for women within health care, the importance of networking, and staying educated.

The vice president and chief pharmacy officer of City of Hope discusses obstacles women face in health care and how diversity, equity, and inclusion can be promoted within the space.

“I see clinical pharmacy specialists (CPS) to be more like the frontline folks that would pretty much work very closely with the providers,” according to a CPS at City of Hope.

Tune into this episode of “Public Health Matters” for valuable insights into the intersection of entertainment, health care, and child advocacy, highlighting the importance of creating supportive and interactive environments for pediatric patients.

Panelists provide concluding perspectives on the operationalization of bispecific antibodies for multiple myeloma.

Jon Martin, US commercial lead of biosimilars at Organon, discusses how making their biosimilar Hadlima the preferred product on the Veteran Affairs formulary will help lower treatment costs.

Experts discuss challenges related to the implementation of bispecific antibodies for the treatment of multiple myeloma and emphasize the critical role of interinstitutional collaboration in developing bispecific antibody programs.

There is a growing number of technologies, processes, and treatments being discovered in the quest to extend life.

Experts review comprehensive strategies to enhance patient safety and responsible opioid management across assessment, monitoring, alternatives, and collaboration.

Health care providers discuss how prefilled syringes reduce diversion risks, enhance waste management, and offer cost-effective solutions, ensuring compliance with regulations.

Many psychedelics being studied for clinical use are not "magic mushrooms", rather clinical drugs formulated using good manufacturing practice standards.

In addition to current treatment regimens, 2 experts discuss how available options can vary between adult and pediatric patients.

Experts sheds light on gaps in gender and use of referrals, health literacy, and medication access in the treatment of patients with heart failure.

Investigators continue to conduct regulated and controlled clinical trials to build compelling, high-quality evidence on their therapeutic potential.

Experts discuss their institution’s implementation of step-up dosing for bispecific antibodies and share their best practices.

Pharmacists could raise awareness of heart health and CPR through community outreach programs

In addition to highlighting the difficulties patients face when managing plaque psoriasis and atopic dermatitis, 2 experts describe how pharmacists play a crucial role in treatment.

The model implemented at City of Hope Chicago has been shown to improve provider workloads and enrich pharmacists’ work.

A panel of experts analyze the impact of prefilled syringes on workflows across diverse patient populations, emphasizing cost savings, patient safety, and interdisciplinary collaboration.

Tune into this episode of "Public Health Matters" to learn about the importance of cultural competence when addressing health care disparities and promoting health equity in diverse communities as well as special guest Dr. Jose Cucalon Calderon's advocacy work.

Experts explore the cost-saving benefits of single-dose prefilled syringes over vials—reducing waste, improving workflow, and enhancing patient care.

Gabriel Hinojosa, PharmD, BCOP, explores unmet needs and social determinants in multiple myeloma care, envisioning treatment advancements amid evolving complexities and patient disparities.

Pharmacists can raise awareness about heart health during American Heart Month

Matthew Pianko, MD, outlines the logistical considerations involved when implementing bispecific antibodies for the treatment of multiple myeloma, including the roles of the project champion and other stakeholders as part of a multidisciplinary team.

California's Stop Dangerous Pharmacies Act aims to improve patient safety by establishing new pharmacy staffing regulations and a medication error reporting system, arising from understaffed conditions.

Nutrition is foundational to health, but healthy eating does not look the same for everyone.

Experts discuss advantages of prefilled syringes in opioid delivery—reducing errors, enhancing safety, and minimizing waste—while providing insights on optimizing dosage forms.

Experts explore using technology and data analytics to enhance opioid stewardship programs, addressing challenges health care professionals face, and providing strategies for effective patient care, leveraging data, and fostering supportive environments.